Annexin Pharmaceuticals' CEO, Anders Haegerstrand, Chief Scientific and Medical Officer, Anna Frostegård, and Head of Therapeutic Area Oncology, Alain Thibault, present the company’s strategic priorities and its commercial roll-out. Watch the replay from March 7.
LÄS MER